Inspired by engaging with the GI community at ESMOGI24 – Agenus

Agenus shared on LinkedIn:

“That’s a wrap on ESMOGI24! Our team was inspired by engaging with the GI community and sharing the latest advancements from our BOT/BAL therapy, including new data in neoadjuvant colon cancer.

Exciting times ahead for the future of cancer care.”